Panagiotou E - Search Results

1

CD24: A Novel Target for Cancer Immunotherapy.

Panagiotou E, Syrigos NK, Charpidou A, Kotteas E, Vathiotis IA. Panagiotou E, et al. J Pers Med. 2022 Jul 28;12(8):1235. doi: 10.3390/jpm12081235. J Pers Med. 2022. PMID: 36013184 Free PMC article. Review.

2

Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials.

Panagiotou E, Gomatou G, Trontzas IP, Syrigos N, Kotteas E. Panagiotou E, et al. Clin Transl Oncol. 2022 Feb;24(2):161-192. doi: 10.1007/s12094-021-02688-5. Epub 2021 Aug 7. Clin Transl Oncol. 2022. PMID: 34363593 Review.

3

BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it.

Tsamis I, Gomatou G, Chachali SP, Trontzas IP, Patriarcheas V, Panagiotou E, Kotteas E. Tsamis I, et al. Among authors: panagiotou e. Clin Transl Oncol. 2023 Jan;25(1):10-20. doi: 10.1007/s12094-022-02849-0. Epub 2022 Jun 21. Clin Transl Oncol. 2023. PMID: 35729451 Review.

4

Emerging therapies in thymic epithelial tumors (Review).

Dapergola A, Gomatou G, Trontzas I, Panagiotou E, Dimakakos E, Syrigos N, Kotteas E. Dapergola A, et al. Among authors: panagiotou e. Oncol Lett. 2023 Jan 16;25(2):84. doi: 10.3892/ol.2023.13670. eCollection 2023 Feb. Oncol Lett. 2023. PMID: 36760515 Free PMC article. Review.

5

Pulmonary benign metastasizing leiomyoma: a case report.

Panagiotou E, Vamvakaris I, Syrigos NK, Kotteas E. Panagiotou E, et al. Monaldi Arch Chest Dis. 2023 Feb 16;94(1). doi: 10.4081/monaldi.2023.2411. Monaldi Arch Chest Dis. 2023. PMID: 36807647 Free article.

6

High-dose bevacizumab for radiation-induced brain necrosis: a case report.

Panagiotou E, Charpidou A, Fyta E, Nikolaidou V, Stournara L, Syrigos A, Gkiozos I. Panagiotou E, et al. CNS Oncol. 2023 Sep 1;12(3):CNS98. doi: 10.2217/cns-2023-0002. Epub 2023 May 4. CNS Oncol. 2023. PMID: 37140173 Free PMC article.

7

Eligibility for screening with low-dose CT in a real-world cohort of patients with lung cancer in Greece: A brief report.

Livanou ME, Syrigos NK, Montgomery A, Moeckel C, Panagiotou E, Charpidou A, Mouratidis I, Georgakopoulos-Soares I, Vathiotis IA. Livanou ME, et al. Among authors: panagiotou e. Lung Cancer. 2023 Dec;186:107424. doi: 10.1016/j.lungcan.2023.107424. Epub 2023 Nov 17. Lung Cancer. 2023. PMID: 37979487

8

Molecular interactions of antibodies with PD-1/PD-L1 proteins.

Vasilakaki S, Vathiotis I, Panagiotou E, Dimakakos E, Gomatou G, Kotteas E. Vasilakaki S, et al. Among authors: panagiotou e. Immunotherapy. 2024 Jan;16(1):21-28. doi: 10.2217/imt-2023-0165. Epub 2023 Dec 6. Immunotherapy. 2024. PMID: 38054258

9

Endocrine Immune-Related Adverse Events Are Independent Predictors of Survival in Patients with Lung Cancer.

Panagiotou E, Ntouraki S, Vathiotis IA, Livanou ME, Trimis A, Evangelou G, Charpidou A, Syrigos K, Peppa M. Panagiotou E, et al. Cancers (Basel). 2024 May 1;16(9):1764. doi: 10.3390/cancers16091764. Cancers (Basel). 2024. PMID: 38730716 Free PMC article.

10

Prolonged SARS-CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 Therapy.

Papanikolopoulou A, Thimis V, Antonogiannaki E, Rapti V, Tsiakos K, Krallis G, Ntouraki S, Kokkotis G, Panagiotou E, Sakka V, Kakalou E, Nitsotolis T, Poulakou G, Syrigos KN. Papanikolopoulou A, et al. Among authors: panagiotou e. In Vivo. 2023 Jan-Feb;37(1):461-467. doi: 10.21873/invivo.13100. In Vivo. 2023. PMID: 36593037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page